AEON Biopharma (AEON)

• Market cap: $13.4M
• 1 day: 1.66%
• 5 days: -5.14%
• 1 month: -22.94%
• 3 months: -65.66%
• 6 months: -71.64%
• Year to date: -75.22%
• 1 year: -64.73%
• 5 years: -99.96%
• 10 years: -99.96%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Employees: 8